PMP2
Basic information
Region (hg38): 8:81440326-81447439
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease, demyelinating, type 1G (Moderate), mode of inheritance: AD
- Charcot-Marie-Tooth disease, demyelinating, type 1G (Strong), mode of inheritance: AD
- Charcot-Marie-Tooth disease, demyelinating, type 1G (Supportive), mode of inheritance: AD
- Charcot-Marie-Tooth disease (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, demyelinating, type 1G | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 26257172; 26828946; 27009151; 30249361 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PMP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 45 | 59 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 1 | 1 | 6 | ||
non coding | 20 | 25 | ||||
Total | 0 | 4 | 52 | 36 | 9 |
Variants in PMP2
This is a list of pathogenic ClinVar variants found in the PMP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-81443283-A-G | Benign (May 14, 2021) | |||
8-81443386-A-G | Charcot-Marie-Tooth disease, demyelinating, type 1G | Benign (Oct 25, 2021) | ||
8-81443401-G-A | Likely benign (Nov 12, 2024) | |||
8-81443402-A-G | Inborn genetic diseases | Uncertain significance (Aug 07, 2023) | ||
8-81443402-A-T | Uncertain significance (Mar 23, 2023) | |||
8-81443403-C-T | Likely benign (Oct 07, 2024) | |||
8-81443409-C-T | Inborn genetic diseases | Uncertain significance (May 08, 2024) | ||
8-81443428-C-T | Uncertain significance (Mar 03, 2024) | |||
8-81443430-C-T | Uncertain significance (Jul 01, 2024) | |||
8-81443431-G-A | Likely benign (Sep 29, 2023) | |||
8-81443432-C-T | PMP2-related disorder | Benign (Feb 02, 2025) | ||
8-81443444-C-T | Uncertain significance (May 09, 2023) | |||
8-81443446-T-C | Likely benign (Apr 09, 2024) | |||
8-81443456-AAG-A | Likely benign (Mar 01, 2024) | |||
8-81443456-AAGAG-A | Uncertain significance (Nov 01, 2023) | |||
8-81443464-G-C | Likely benign (Jun 14, 2022) | |||
8-81443478-C-G | Benign (May 15, 2021) | |||
8-81444481-G-C | Likely benign (May 06, 2021) | |||
8-81444482-A-C | Likely benign (May 06, 2021) | |||
8-81444483-A-T | Likely benign (May 06, 2021) | |||
8-81444484-G-C | Likely benign (May 06, 2021) | |||
8-81444485-TAAAG-T | Likely benign (May 18, 2021) | |||
8-81444488-A-G | Likely benign (Aug 23, 2022) | |||
8-81444489-G-A | Likely benign (Oct 03, 2023) | |||
8-81444490-A-C | Likely benign (May 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PMP2 | protein_coding | protein_coding | ENST00000256103 | 4 | 7198 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00847 | 0.810 | 125722 | 0 | 8 | 125730 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0996 | 67 | 69.3 | 0.966 | 0.00000334 | 863 |
Missense in Polyphen | 17 | 17.503 | 0.97127 | 247 | ||
Synonymous | 0.554 | 22 | 25.6 | 0.861 | 0.00000135 | 241 |
Loss of Function | 1.05 | 4 | 6.99 | 0.572 | 3.93e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000359 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in lipid transport protein in Schwann cells. May bind cholesterol. {ECO:0000269|PubMed:20421974}.;
- Pathway
- Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway
(Consensus)
Recessive Scores
- pRec
- 0.364
Intolerance Scores
- loftool
- 0.585
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.22
Haploinsufficiency Scores
- pHI
- 0.146
- hipred
- N
- hipred_score
- 0.310
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.262
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pmp2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- membrane organization
- Cellular component
- cytoplasm;myelin sheath;extracellular exosome
- Molecular function
- fatty acid binding;protein binding;cholesterol binding